James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 15,000 shares at $3.41 ($52K) on 2011-08-01, disclosed to the SEC on 2011-08-01.
Scheduled sale ($52k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 5,000 | $17K | 32.9% |
| 2 | $3.47 | 10,000 | $35K | 67.1% |
| Total | $3.45 avg | 15,000 | $52K | 100% |
| Filing → |
| CORT | SELL | 2026-07-17 | $883K | — | Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |